1. CoreAge Rx: sponsored first placement
CoreAge's Smooth Move page names tretinoin, niacinamide and vitamin C and advertises a starting price of $42 per month. It also describes free delivery, no membership fees and an online assessment with prescribing conditional on clinician approval. This is a relatively straightforward public outline, but the starting amount does not establish every future invoice.
The main unresolved details are the concentrations, final quantity, supply period and dispensing pharmacy for the individual order. Those belong in the written prescription and service terms. Our CoreAge Rx review examines the offer in depth and distinguishes the provider's ingredient claims from evidence about the exact finished mixture.
A sponsored first position is a navigation choice with a commercial reason. It should not be used as a shortcut around consultation, comparison or an approved alternative when that is clinically appropriate. Readers should ask why a compounded prescription is being proposed and how the selected preparation fits the actual treatment need.
2. Curology: clarify the HydroTret quote
Curology's HydroTret Rx page describes a personalized, hydration-focused formula with up to three selected actives. It also acknowledges a version without tretinoin. That makes the final prescription more important than the product name. Someone specifically evaluating tretinoin should confirm whether it appears in their own formula and at what concentration.
The current public pricing records disagree. The product page shows a $29.95 monthly subscription offer, while the support article lists HydroTret at $34.95 monthly, billed as $69.90 per shipment. This comparison does not resolve that conflict in favor of the lower number. Obtain the actual renewal quote, trial terms and shipping interval before comparing totals.
Curology's support documentation also describes consultation credits. That is a useful distinction from generic promises of ongoing access. The Curology review covers the price discrepancy, possible ingredients and the questions that follow from its published care model.
3. Dermatica: compare the actual delivery date
Dermatica's US personalized treatment page lists tretinoin among possible prescription ingredients and describes formula adjustments over time. It also names components of its SmartBase cream. These details describe the service's approach; they are not a recommendation to choose the strongest percentage shown on the page.
The pricing page lists $59.90 for a two-bottle plan, described as every two months, while also stating that delivery occurs every fifty-six days. Those phrases should not be silently treated as the same billing calendar. Check the next order date and the complete amount charged rather than relying only on a monthly equivalent.
The Dermatica review keeps the prescription offer distinct from other products promoted on the site. It also explains why free shipping and flexible delivery settings do not answer clinical questions about irritation, treatment goals or the need to change a formula.
4. Agency: use the current Night Renew terms
Agency now calls its personalized evening treatment Night Renew Rx, formerly Future Formula. The current product page lists 24 grams as a sixty-day supply for $130. Its support article describes automatic sixty-day orders, free shipping and applicable tax, with optional products affecting the total.
The possible ingredient list is broad, and not every formula contains tretinoin. A reader should identify the proposed actives before comparing Night Renew with a simpler tretinoin preparation. Its public biological-pathway and comparative-strength claims are provider claims, not measurements performed by this publication.
Agency's consultation-credit terms are another item to review before enrolling. The Agency review explains the current product name, per-order charge and questions about ongoing access. Older articles using a different price or formula name should not override the current written offer.
Five questions make the comparison more useful
First, identify the medicine: what actives, strengths and base will be dispensed? Second, identify the clinical purpose and why that formula is suitable. Third, obtain the complete price and actual next charge date. Fourth, find the dispensing pharmacy and a way to contact it. Fifth, understand how to reach a clinician and what happens when the plan needs review.
The label decoder, glossary and subscription cost guide cover different parts of that record. They do not recommend a dose, determine eligibility or collect health information. A service can be convenient while still leaving a question unanswered; it is better to preserve that gap than infer a favorable answer from polished marketing.
Keep approval status and personal suitability separate
FDA explains that compounded preparations are not approved generics and are not reviewed for safety, effectiveness and quality through the same premarket approval process. A licensed clinician may consider compounding for a patient's medical need, but personalization is not inherently proof of a superior drug. Discuss relevant approved options rather than assuming a multi-ingredient prescription is always preferable.
Check pharmacy licensing through the appropriate state board and disclose relevant health history and other products during the consultation. Use the first-month question guide to understand follow-up before treatment begins. The best outcome from this list is a clearer, better-documented decision with a qualified professional, not a claim that one sponsored position fits every reader.